LysoPE(0:0/22:5(4Z,7Z,10Z,13Z,16Z))
|
Basic information |
| Metabolite name | LysoPE(0:0/22:5(4Z,7Z,10Z,13Z,16Z)) |
 | HMDB0011494 |
 |
N/A |
 |
53480943 |
| Synonyms | NA |
| No. of studies | 2 |
|
Basic information |
| Metabolite name | LysoPE(0:0/22:5(4Z,7Z,10Z,13Z,16Z)) |
| HMDB0011494 |
|
N/A |
|
53480943 |
| Synonyms | NA |
| No. of studies | 2 |
|
Relationship between LysoPE(0:0/22:5(4Z,7Z,10Z,13Z,16Z)) and depression (count: 2) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M469 | Type1 | Parkinson's disease with depression group vs. Parkinson's disease without depression group | Plasma | Human | Down |
| Study M609 | Type2 | LPS + NBP group vs. LPS group | Hippocampus | Sprague-Dawley rat | Up |